Actuate Therapeutics Inc
(ACTU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Operating Expenses | 25,161 | 24,974 |
| Operating Income | -25,161 | -24,974 |
| Interest Expense | 19 | 44 |
| Other Income | -2,106 | 273 |
| Pre-tax Income | -27,285 | -24,745 |
| Net Income Continuous | -27,285 | -24,745 |
| Net Income | $-27,285 | $-24,745 |
| EPS Basic Total Ops | -3.26 | -17.24 |
| EPS Basic Continuous Ops | -3.26 | -17.24 |
| EPS Diluted Total Ops | -3.26 | -17.24 |
| EPS Diluted Continuous Ops | -3.26 | -17.24 |
| EPS Diluted Before Non-Recurring Items | -3.26 | -17.24 |
| EBITDA(a) | $-25,161 | $-24,974 |